Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MLYCD | O95822 | 13/20 | 0.59 |
| ▸ | NPC1 | O15118 | 1/20 | 0.58 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.58 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.58 |
| ▸ | RAB9A | P51151 | 1/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.57 |
| ▸ | CES1 | P23141 | 1/20 | 0.54 |
| ▸ | PLK1 | P53350 | 1/20 | 0.52 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.50 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29137248 | 0.86 | ALDH1A1 (0.55) | MLYCDNPC1CYP1A2CYP2C19RAB9A | |
| SCHEMBL9560910 | 0.84 | MLYCD (0.57) | MLYCDNPC1RAB9AALDH1A1CES1 | |
| SCHEMBL3128806 | 0.82 | ALDH1A1 (0.55) | MLYCDNPC1CYP1A2CYP2C19RAB9A | |
| SCHEMBL3266774 | 0.81 | MLYCD (0.58) | MLYCDALDH1A1PLK1 | |
| SCHEMBL7051795 | 0.81 | CES1 (0.56) | MLYCDCES1 | |
| SCHEMBL1628100 | 0.81 | ALDH1A1 (0.59) | NPC1CYP1A2CYP2C19RAB9ASMN1; SMN2 | |
| SCHEMBL7051793 | 0.81 | CES1 (0.56) | MLYCDCES1 | |
| SCHEMBL13668085 | 0.80 | THRA (0.56) | MLYCDCES1 | |
| SCHEMBL9770874 | 0.80 | ALDH1A1 (0.48) | MLYCDNPC1CYP1A2CYP2C19RAB9A | |
| SCHEMBL26660468 | 0.80 | FAAH (0.64) | MLYCDALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250163224-A1 | POLYMER AND PREPARATION METHOD THEREFOR, AND ANION-EXCHANGE MEMBRANE | Tan Kah Kee Innovation Laboratory (CN) | 2025-05-22 | — | — | US | claimed |
| US-12297327-B1 | Polymer and preparation method therefor, and anion-exchange membrane | Tan Kah Kee Innovation Laboratory (CN) | 2025-05-13 | — | — | US | claimed |
| WO-2023217050-A1 | POLYMER AND PREPARATION METHOD THEREFOR, AND ANION-EXCHANGE MEMBRANE | 嘉庚创新实验室 | 2023-11-16 | — | — | WO | claimed |
| CN-114989437-A | Polymer, preparation method thereof and anion exchange membrane | 嘉庚创新实验室 | 2022-09-02 | — | — | CN | claimed |
| US-7087789-B2 | Methods for nucleophilic fluoromethylation | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2006-08-08 | — | — | US | claimed |
| US-20250163224-A1 | POLYMER AND PREPARATION METHOD THEREFOR, AND ANION-EXCHANGE MEMBRANE | Tan Kah Kee Innovation Laboratory (CN) | 2025-05-22 | — | — | US | disclosed |
| US-12297327-B1 | Polymer and preparation method therefor, and anion-exchange membrane | Tan Kah Kee Innovation Laboratory (CN) | 2025-05-13 | — | — | US | disclosed |
| WO-2023217050-A1 | POLYMER AND PREPARATION METHOD THEREFOR, AND ANION-EXCHANGE MEMBRANE | 嘉庚创新实验室 | 2023-11-16 | — | — | WO | disclosed |
| CN-110862299-B | Method for synthesizing 9-hydroxy-9 trifluoromethyl fluorene compound | 浙江工业大学 | 2022-10-11 | — | — | CN | disclosed |
| CN-114989437-A | Polymer, preparation method thereof and anion exchange membrane | 嘉庚创新实验室 | 2022-09-02 | — | — | CN | disclosed |
| CN-110862299-A | Method for synthesizing 9-hydroxy-9 trifluoromethyl fluorene compound | 浙江工业大学 | 2020-03-06 | — | — | CN | disclosed |
| WO-2015187684-A1 | TANK-BINDING KINASE INHIBITOR COMPOUNDS | GILEAD SCIENCES, INC. (US) | 2015-12-10 | — | — | WO | disclosed |
| US-20150031668-A1 | CHROMAN DERIVATIVES AS TRPM8 INHIBITORS | AMGEN INC (US) | 2015-01-29 | — | — | US | disclosed |
| US-20110070657-A1 | DETECTING IONS AND MEASURING ION CONCENTRATIONS | THE GENERAL HOSPITAL CORPORATION (US) | 2011-03-24 | — | — | US | disclosed |
| EP-1045836-B1 | PYRIDONES AS SRC FAMILY SH2 DOMAIN INHIBITORS | BOEHRINGER INGELHEIM PHARMA (US) | 2008-03-05 | — | — | EP | disclosed |
| EP-0545891-A2 | Aldehyde compounds and derivatives thereof useful as intermediates in the preparation of insectical ether compounds | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1993-06-09 | — | — | EP | disclosed |
| US-4840971-A | INSECTICIDES, MITICIDES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1989-06-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150031668-A1 | CHROMAN DERIVATIVES AS TRPM8 INHIBITORS | TRPM8, TRPM5, TRPM7 | MLYCD 2833/4885NPC1 702/4885CYP1A2 2160/4885 |
| US-20110070657-A1 | DETECTING IONS AND MEASURING ION CONCENTRATIONS | CA2, SLC30A5, CA3 | MLYCD 3370/4885NPC1 453/4885CYP1A2 4254/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.